Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05305924
Title Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Methodist Hospital Research Institute
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Houston Methodist Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field